Micro-Droplet Platform for Exploring the Mechanism of Mixed Field Agglutination in B<sub>3</sub> Subtype

B<sub>3</sub> is the most common subtype of blood group B in the Taiwanese population, and most of the B<sub>3</sub> individuals in the Taiwanese population have the IVS3 + 5 G > A (rs55852701) gene variation. Additionally, a typical mixed field agglutination is observed w...

Full description

Bibliographic Details
Main Authors: Ding-Ping Chen, Chen Chen, Pei-Yu Wu, Yen-Heng Lin, Wei-Tzu Lin, Yi-Liang Yan
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Biosensors
Subjects:
Online Access:https://www.mdpi.com/2079-6374/11/8/276
_version_ 1797524483984064512
author Ding-Ping Chen
Chen Chen
Pei-Yu Wu
Yen-Heng Lin
Wei-Tzu Lin
Yi-Liang Yan
author_facet Ding-Ping Chen
Chen Chen
Pei-Yu Wu
Yen-Heng Lin
Wei-Tzu Lin
Yi-Liang Yan
author_sort Ding-Ping Chen
collection DOAJ
description B<sub>3</sub> is the most common subtype of blood group B in the Taiwanese population, and most of the B<sub>3</sub> individuals in the Taiwanese population have the IVS3 + 5 G > A (rs55852701) gene variation. Additionally, a typical mixed field agglutination is observed when the B<sub>3</sub> subtype is tested with anti-B antibody or anti-AB antibody. The molecular biology of the gene variation in the B<sub>3</sub> subtype has been identified, however, the mechanism of the mixed field agglutination caused by the type B<sub>3</sub> blood samples is still unclear. Therefore, the purpose of this study was to understand the reason for the mixed field agglutination caused by B<sub>3</sub>. A micro-droplet platform was used to observe the agglutination of type B and type B<sub>3</sub> blood samples in different blood sample concentrations, antibody concentrations, and at reaction times. We found that the agglutination reaction in every droplet slowed down with an increase in the dilution ratio of blood sample and antibody, whether type B blood or type B<sub>3</sub> blood was used. However, as the reaction time increased, the complete agglutination in the droplet was seen in type B blood, while the mixed field agglutination still occurred in B<sub>3</sub> within 1 min. In addition, the degree of agglutination was similar in each droplet, which showed high reproducibility. As a result, we inferred that there are two types of cells in the B<sub>3</sub> subtype that simultaneously create a mixed field agglutination, rather than each red blood cell carrying a small amount of antigen, resulting in less agglutination.
first_indexed 2024-03-10T08:58:04Z
format Article
id doaj.art-0390ca90cad14473843ec8e33495d645
institution Directory Open Access Journal
issn 2079-6374
language English
last_indexed 2024-03-10T08:58:04Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Biosensors
spelling doaj.art-0390ca90cad14473843ec8e33495d6452023-11-22T06:57:44ZengMDPI AGBiosensors2079-63742021-08-0111827610.3390/bios11080276Micro-Droplet Platform for Exploring the Mechanism of Mixed Field Agglutination in B<sub>3</sub> SubtypeDing-Ping Chen0Chen Chen1Pei-Yu Wu2Yen-Heng Lin3Wei-Tzu Lin4Yi-Liang Yan5Department of Laboratory Medicine, Chang Gung Memorial Hospital, Taoyuan City 333, TaiwanDepartment of Electronic Engineering, Chang Gung University, Taoyuan City 333, TaiwanDepartment of Electronic Engineering, Chang Gung University, Taoyuan City 333, TaiwanDepartment of Electronic Engineering, Chang Gung University, Taoyuan City 333, TaiwanDepartment of Laboratory Medicine, Chang Gung Memorial Hospital, Taoyuan City 333, TaiwanDepartment of Laboratory Medicine, Chang Gung Memorial Hospital, Taoyuan City 333, TaiwanB<sub>3</sub> is the most common subtype of blood group B in the Taiwanese population, and most of the B<sub>3</sub> individuals in the Taiwanese population have the IVS3 + 5 G > A (rs55852701) gene variation. Additionally, a typical mixed field agglutination is observed when the B<sub>3</sub> subtype is tested with anti-B antibody or anti-AB antibody. The molecular biology of the gene variation in the B<sub>3</sub> subtype has been identified, however, the mechanism of the mixed field agglutination caused by the type B<sub>3</sub> blood samples is still unclear. Therefore, the purpose of this study was to understand the reason for the mixed field agglutination caused by B<sub>3</sub>. A micro-droplet platform was used to observe the agglutination of type B and type B<sub>3</sub> blood samples in different blood sample concentrations, antibody concentrations, and at reaction times. We found that the agglutination reaction in every droplet slowed down with an increase in the dilution ratio of blood sample and antibody, whether type B blood or type B<sub>3</sub> blood was used. However, as the reaction time increased, the complete agglutination in the droplet was seen in type B blood, while the mixed field agglutination still occurred in B<sub>3</sub> within 1 min. In addition, the degree of agglutination was similar in each droplet, which showed high reproducibility. As a result, we inferred that there are two types of cells in the B<sub>3</sub> subtype that simultaneously create a mixed field agglutination, rather than each red blood cell carrying a small amount of antigen, resulting in less agglutination.https://www.mdpi.com/2079-6374/11/8/276B<sub>3</sub> subtypingmicrofluidicsblood agglutination
spellingShingle Ding-Ping Chen
Chen Chen
Pei-Yu Wu
Yen-Heng Lin
Wei-Tzu Lin
Yi-Liang Yan
Micro-Droplet Platform for Exploring the Mechanism of Mixed Field Agglutination in B<sub>3</sub> Subtype
Biosensors
B<sub>3</sub> subtyping
microfluidics
blood agglutination
title Micro-Droplet Platform for Exploring the Mechanism of Mixed Field Agglutination in B<sub>3</sub> Subtype
title_full Micro-Droplet Platform for Exploring the Mechanism of Mixed Field Agglutination in B<sub>3</sub> Subtype
title_fullStr Micro-Droplet Platform for Exploring the Mechanism of Mixed Field Agglutination in B<sub>3</sub> Subtype
title_full_unstemmed Micro-Droplet Platform for Exploring the Mechanism of Mixed Field Agglutination in B<sub>3</sub> Subtype
title_short Micro-Droplet Platform for Exploring the Mechanism of Mixed Field Agglutination in B<sub>3</sub> Subtype
title_sort micro droplet platform for exploring the mechanism of mixed field agglutination in b sub 3 sub subtype
topic B<sub>3</sub> subtyping
microfluidics
blood agglutination
url https://www.mdpi.com/2079-6374/11/8/276
work_keys_str_mv AT dingpingchen microdropletplatformforexploringthemechanismofmixedfieldagglutinationinbsub3subsubtype
AT chenchen microdropletplatformforexploringthemechanismofmixedfieldagglutinationinbsub3subsubtype
AT peiyuwu microdropletplatformforexploringthemechanismofmixedfieldagglutinationinbsub3subsubtype
AT yenhenglin microdropletplatformforexploringthemechanismofmixedfieldagglutinationinbsub3subsubtype
AT weitzulin microdropletplatformforexploringthemechanismofmixedfieldagglutinationinbsub3subsubtype
AT yiliangyan microdropletplatformforexploringthemechanismofmixedfieldagglutinationinbsub3subsubtype